158 related articles for article (PubMed ID: 15920025)
1. Bone morphogenetic protein receptor-2 and pulmonary arterial hypertension: unraveling a riddle inside an enigma?
Stewart DJ
Circ Res; 2005 May; 96(10):1033-5. PubMed ID: 15920025
[No Abstract] [Full Text] [Related]
2. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
[TBL] [Abstract][Full Text] [Related]
3. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
4. The mouse through the looking glass: a new door into the pathophysiology of pulmonary hypertension.
Rabinovitch M
Circ Res; 2004 Apr; 94(8):1001-4. PubMed ID: 15117827
[No Abstract] [Full Text] [Related]
5. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
6. Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation in patients with primary pulmonary hypertension.
Rabinovitch M
J Clin Invest; 2001 Oct; 108(8):1109-11. PubMed ID: 11602617
[No Abstract] [Full Text] [Related]
7. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
[TBL] [Abstract][Full Text] [Related]
8. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
9. Spatio-temporal diversity of apoptosis within the vascular wall in pulmonary arterial hypertension: heterogeneous BMP signaling may have therapeutic implications.
Michelakis ED
Circ Res; 2006 Feb; 98(2):172-5. PubMed ID: 16456109
[No Abstract] [Full Text] [Related]
10. [Primary pulmonary hypertension].
Otsuka F; Makino H
Nihon Rinsho; 2005 Oct; 63 Suppl 10():450-7. PubMed ID: 16279681
[No Abstract] [Full Text] [Related]
11. Mutations of bone morphogenetic protein receptor type II are not found in patients with pulmonary hypertension and underlying connective tissue diseases.
Tew MB; Arnett FC; Reveille JD; Tan FK
Arthritis Rheum; 2002 Oct; 46(10):2829-30. PubMed ID: 12384956
[No Abstract] [Full Text] [Related]
12. Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells.
Pouliot F; Blais A; Labrie C
Cancer Res; 2003 Jan; 63(2):277-81. PubMed ID: 12543773
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle.
West J; Fagan K; Steudel W; Fouty B; Lane K; Harral J; Hoedt-Miller M; Tada Y; Ozimek J; Tuder R; Rodman DM
Circ Res; 2004 Apr; 94(8):1109-14. PubMed ID: 15031260
[TBL] [Abstract][Full Text] [Related]
14. Genetic clues to the cause of primary pulmonary hypertension.
Loscalzo J
N Engl J Med; 2001 Aug; 345(5):367-71. PubMed ID: 11484696
[No Abstract] [Full Text] [Related]
15. Signaling molecules in nonfamilial pulmonary hypertension.
Du L; Sullivan CC; Chu D; Cho AJ; Kido M; Wolf PL; Yuan JX; Deutsch R; Jamieson SW; Thistlethwaite PA
N Engl J Med; 2003 Feb; 348(6):500-9. PubMed ID: 12571257
[TBL] [Abstract][Full Text] [Related]
16. [Mutations of genes coding for TGF-beta receptors (BMPR2 and ALK-1) in primary pulmonary arterial hypertension].
Humbert M
J Soc Biol; 2002; 196(1):53-8. PubMed ID: 12134634
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
[TBL] [Abstract][Full Text] [Related]
18. [The role of Smads and related transcription factors in the signal transduction of bone morphogenetic protein inducing bone formation].
Xu XL; Dai KR; Tang TT
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Sep; 17(5):359-62. PubMed ID: 14551929
[TBL] [Abstract][Full Text] [Related]
19. [BMP receptors and signal transduction].
Hayashi M; Imamura T; Miyazono K
Nihon Rinsho; 2005 Oct; 63 Suppl 10():399-403. PubMed ID: 16279670
[No Abstract] [Full Text] [Related]
20. [Pulmonary arterial hypertension and BMP system abnormality].
Otsuka F
Nihon Rinsho; 2008 Nov; 66(11):2083-90. PubMed ID: 19051724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
